Robert Shearer

1.8k total citations
33 papers, 804 citations indexed

About

Robert Shearer is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Robert Shearer has authored 33 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 9 papers in Urology. Recurrent topics in Robert Shearer's work include Bladder and Urothelial Cancer Treatments (6 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Urological Disorders and Treatments (6 papers). Robert Shearer is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Urological Disorders and Treatments (6 papers). Robert Shearer collaborates with scholars based in United Kingdom, Ireland and United States. Robert Shearer's co-authors include David P. Dearnaley, Michael Bailey, Rosalind A. Eeles, Audrey Ardern‐Jones, Justin H. Davies, Anna Dowe, Bruce A.J. Ponder, Douglas F. Easton, Jo A. Kelly and J. Gelister and has published in prestigious journals such as Cell, Cancer Research and The Journal of Urology.

In The Last Decade

Robert Shearer

33 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Shearer United Kingdom 16 334 300 238 134 132 33 804
Piero De Carli Italy 15 209 0.6× 221 0.7× 399 1.7× 174 1.3× 135 1.0× 34 821
Miriam Konichezky Israel 12 324 1.0× 217 0.7× 245 1.0× 42 0.3× 100 0.8× 20 562
Yasunori Harada Japan 10 195 0.6× 160 0.5× 90 0.4× 42 0.3× 85 0.6× 23 447
Jeffrey Reese United States 12 276 0.8× 168 0.6× 437 1.8× 170 1.3× 170 1.3× 25 851
Laury Finn United States 13 302 0.9× 164 0.5× 282 1.2× 24 0.2× 241 1.8× 22 671
Zhanyong Bing United States 16 166 0.5× 253 0.8× 173 0.7× 23 0.2× 129 1.0× 48 586
Madeleine Joubert France 13 80 0.2× 279 0.9× 172 0.7× 33 0.2× 173 1.3× 36 682
Choichiro Ozu Japan 12 146 0.4× 158 0.5× 247 1.0× 63 0.5× 269 2.0× 22 579
Carlos E. Bermejo United States 12 154 0.5× 163 0.5× 250 1.1× 79 0.6× 128 1.0× 15 510
William Westra United States 10 165 0.5× 344 1.1× 89 0.4× 22 0.2× 195 1.5× 11 736

Countries citing papers authored by Robert Shearer

Since Specialization
Citations

This map shows the geographic impact of Robert Shearer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Shearer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Shearer more than expected).

Fields of papers citing papers by Robert Shearer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Shearer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Shearer. The network helps show where Robert Shearer may publish in the future.

Co-authorship network of co-authors of Robert Shearer

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Shearer. A scholar is included among the top collaborators of Robert Shearer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Shearer. Robert Shearer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guðjόnsson, Þorkell, Matthias Altmeyer, Velibor Savic, et al.. (2014). TRIP12 and UBR5 Suppress Spreading of Chromatin Ubiquitylation at Damaged Chromosomes. Cell. 159(6). 1476–1477. 2 indexed citations
2.
Easton, Douglas, Steven M. Edwards, Sarah Jefferies, et al.. (2001). Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics. 11(4). 325–330. 76 indexed citations
3.
Edwards, Stephen M., Ralph Minter, Rifat Hamoudi, et al.. (1999). Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival. International Journal of Cancer. 84(5). 458–465. 121 indexed citations
4.
Ardern‐Jones, Audrey, Rifat Hamoudi, DF Easton, et al.. (1997). No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. British Journal of Cancer. 76(8). 992–1000. 18 indexed citations
5.
Eeles, Rosalind A., David P. Dearnaley, Audrey Ardern‐Jones, et al.. (1997). Familial prostate cancer: the evidence and the Cancer Research Campaign/British Prostate Group (CRC/BPG) UK Familial Prostate Cancer Study. British Journal of Urology. 79(S1). 8–14. 20 indexed citations
6.
Narayan, Perinchery, John Trachtenberg, Herbert Lepor, et al.. (1996). A dose-response study of the effect of flutamide on benign prostatic hyperplasia: Results of a multicenter study. Urology. 47(4). 497–504. 19 indexed citations
7.
MORRIS, S. B., et al.. (1995). Superficial bladder cancer: for how long should a tumour‐free patient have check cystoscopies?. British Journal of Urology. 75(2). 193–196. 31 indexed citations
8.
HAMPSON, S. J., et al.. (1993). LHRH Analogues as Primary Treatment for Urinary Retention in Patients with Prostatic Carcinoma. British Journal of Urology. 71(5). 583–586. 1 indexed citations
9.
Reynard, John & Robert Shearer. (1993). Localised Amyloidosis of the Urinary Bladder. British Journal of Urology. 72(5). 656–656. 7 indexed citations
10.
Shearer, Robert, Justin H. Davies, J. Gelister, & David P. Dearnaley. (1992). Hormonal Cytoreduction and Radiotherapy for Carcinoma of the Prostate. British Journal of Urology. 69(5). 521–524. 57 indexed citations
11.
Shearer, Robert, Martin Rowlands, Grace K. Poon, et al.. (1992). Effects of 4-Hydroxyandrost-4-Ene-3,17-Dione and Its Metabolites on 5α-Reductase Activity and the Androgen Receptor. Journal of enzyme inhibition. 6(2). 141–147. 10 indexed citations
12.
Shearer, Robert. (1991). Prostatic Specific Antigen. British Journal of Urology. 67(1). 1–5. 15 indexed citations
13.
Loosemore, T M, Christopher R.J. Woodhouse, & Robert Shearer. (1991). Role of Ultrasound in the Investigation of Haematuria after Normal Intravenous Urography and Cystoscopy. European Urology. 19(1). 6–7. 4 indexed citations
14.
Rowlands, Martin, John Davies, Robert Shearer, & Mitch Dowsett. (1991). Comparison of Aromatase Activity in Human Prostatic, Testicular and Placental Tissues. Journal of enzyme inhibition. 4(4). 307–313. 8 indexed citations
15.
Rew, David A., et al.. (1988). Malignant Fibrous Histiocytomas Associated with the Urinary Tract. British Journal of Urology. 62(5). 488–489. 1 indexed citations
16.
Shearer, Robert, et al.. (1988). Adjuvant Chemotherapy in T3 Carcinoma of the Bladder A Prospective Trial: Preliminary Report. British Journal of Urology. 62(6). 558–564. 72 indexed citations
17.
Dormandy, John, et al.. (1988). Scrotal Swelling due to Perianeurysmal Fibrosis. British Journal of Urology. 61(6). 536–538. 2 indexed citations
18.
Rainsbury, Richard & Robert Shearer. (1983). An Evaluation of a Simple Stick Test for Pyuria. British Journal of Urology. 55(3). 298–300. 1 indexed citations
19.
Shearer, Robert, et al.. (1981). Prostatism, Obstructive Uropathy and Uraemia Associated with a Urachal Cyst. British Journal of Urology. 53(5). 482–482. 8 indexed citations
20.
Shearer, Robert, et al.. (1973). Oestrogen treatment in carcinoma of the prostate.. BMJ. 3(5870). 51.1–51. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Piero De Carli Breakdown of academic impact, for papers by Miriam Konichezky Breakdown of academic impact, for papers by Yasunori Harada Breakdown of academic impact, for papers by Jeffrey Reese Breakdown of academic impact, for papers by Laury Finn Breakdown of academic impact, for papers by Zhanyong Bing Breakdown of academic impact, for papers by Madeleine Joubert Breakdown of academic impact, for papers by Choichiro Ozu Breakdown of academic impact, for papers by Carlos E. Bermejo Breakdown of academic impact, for papers by William Westra
Rankless by CCL
2026